| References |
Top |
| REF 1 |
p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 2002 Jan 1;62(1):141-51.
|
| REF 2 |
Regulation of murine TGFbeta2 by Pax3 during early embryonic development. J Biol Chem. 2006 Aug 25;281(34):24544-52.
|
| REF 3 |
p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis. Cancer Res. 2014 Mar 15;74(6):1870-1880.
|
| REF 4 |
Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter. J Biol Chem. 2008 Oct 31;283(44):29671-80.
|
| REF 5 |
Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J Biol Chem. 1999 May 28;274(22):15901-7.
|
| REF 6 |
p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively. J Biol Chem. 1999 Mar 19;274(12):7681-8.
|
| REF 7 |
Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1. J Mol Biol. 2008 Mar 28;377(3):668-78.
|
| REF 8 |
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 1999 Apr 16;284(5413):479-82.
|
| REF 9 |
Regulation of beta -catenin transformation by the p300 transcriptional coactivator. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12613-8.
|
| REF 10 |
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature. 2007 Mar 29;446(7135):562-6.
|
| REF 11 |
Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity. Biochem Biophys Res Commun. 2009 May 22;383(1):88-92.
|
| REF 12 |
TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCalpha-dependent signaling pathways. J Cell Physiol. 2010 Aug;224(2):454-64.
|
| REF 13 |
MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol. 2007 Nov 15;179(10):7101-9.
|
| REF 14 |
p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell. 1998 Oct;2(4):405-15.
|
| REF 15 |
Binding and modulation of p53 by p300/CBP coactivators. Nature. 1997 Jun 19;387(6635):823-7.
|
| REF 16 |
A simple method to screen ligands of peroxisome proliferator-activated receptor delta. Eur J Pharm Sci. 2006 Dec;29(5):355-60.
|
| REF 17 |
Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. Oncogene. 2011 Jan 27;30(4):482-93.
|
| REF 18 |
Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J Biol Chem. 2002 Mar 15;277(11):8847-53.
|
| REF 19 |
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol. 2007 Feb;27(4):1280-95.
|
| REF 20 |
Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J Immunol. 2003 Dec 15;171(12):6581-8.
|
| REF 21 |
Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes. 2002 May;51(5):1409-18.
|
| REF 22 |
HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell. 2013 Jun 6;153(6):1327-39.
|
| REF 23 |
Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene. 2010 Jan 14;29(2):201-13.
|
| REF 24 |
Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene. 2003 Jan 9;22(1):151-6.
|
| REF 25 |
Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell. 2004 Jul 2;15(1):83-94.
|
| REF 26 |
Identification of the hypoxia-inducible factor 2 nuclear interactome in melanoma cells reveals master proteins involved in melanoma development. Mol Cell Proteomics. 2013 Mar;12(3):736-48.
|
| REF 27 |
Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis. Nature. 2001 Mar 15;410(6826):387-91.
|
| REF 28 |
ATRA activates and PDGF-BB represses the SM22 promoter through KLF4 binding to, or dissociating from, its cis-DNA elements. Cardiovasc Res. 2011 Jun 1;90(3):464-74.
|
| REF 29 |
Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site. Glia. 2009 Jul;57(9):989-99.
|
| REF 30 |
Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner. J Immunol. 2009 Dec 1;183(11):6981-8.
|
| REF 31 |
An intrinsically disordered region of the acetyltransferase p300 with similarity to prion-like domains plays a role in aggregation. PLoS One. 2012;7(11):e48243.
|
| REF 32 |
Cigarette smoke extract regulates cytosolic phospholipase A2 expression via NADPH oxidase/MAPKs/AP-1 and p300 in human tracheal smooth muscle cells. J Cell Biochem. 2011 Feb;112(2):589-99.
|
| REF 33 |
CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1020-5.
|
| REF 34 |
Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF. J Biol Chem. 2010 Dec 3;285(49):38014-22.
|
| REF 35 |
Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509.
|
| REF 36 |
Acetylation of Sirt2 by p300 attenuates its deacetylase activity. Biochem Biophys Res Commun. 2008 Oct 31;375(4):576-80.
|
| REF 37 |
Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J. 2005 Jan 12;24(1):85-96.
|
| REF 38 |
Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. Cancer Res. 2007 May 15;67(10):4816-26.
|
| REF 39 |
A transcriptional switch mediated by cofactor methylation. Science. 2001 Dec 21;294(5551):2507-11.
|
| REF 40 |
p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain. J Biol Chem. 2005 Dec 16;280(50):41537-45.
|
| REF 41 |
Interaction and functional collaboration of p300 and C/EBPbeta. Mol Cell Biol. 1997 Nov;17(11):6609-17.
|
| REF 42 |
The prostaglandin transporter regulates adipogenesis and aromatase transcription. Cancer Prev Res (Phila). 2011 Feb;4(2):194-206.
|
| REF 43 |
The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription. Mol Endocrinol. 2005 Sep;19(9):2283-98.
|
| REF 44 |
Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell. 1998 Mar;1(4):507-18.
|
| REF 45 |
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol. 2004 Dec;24(24):10954-64.
|
| REF 46 |
Signal transducer and activator of transcription 6 directly regulates human ORMDL3 expression. FEBS J. 2013 May;280(9):2014-26.
|
| REF 47 |
Acetylation-dependent regulation of Skp2 function. Cell. 2012 Jul 6;150(1):179-93.
|
| REF 48 |
Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol. 2003 Apr;23(7):2587-99.
|
| REF 49 |
Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem. 2003 May 2;278(18):16021-9.
|
| REF 50 |
Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8. Cancer Lett. 2010 May 28;291(2):237-45.
|
| REF 51 |
Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways. J Biol Chem. 2004 Jul 16;279(29):30474-9.
|
